Not applicableStudy completedNCT07615166
What this trial is testing
Low-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in Individuals Initiating Therapy in Routine Clinical Practice
Who this might be right for
Atherosclerotic Cardiovascular Disease
Sanofi 996